← Leaderboards
Francesca Polverino
University Of Arizona
$4,920,719
Attributed
$5,719,098
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,719,098 · 3
By mechanism
R01$5,719,098 · 3
Top collaborators
- Suzanne M Cloonan1 shared
- Farrah Kheradmand1 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Zhiyu Dai$7,862,593
- Anup Srivastava$383,750
Others in their field
Other Emerging Leaders on “Cell Physiology”
- Evan Z Macosko · Broad Institute, Inc.$28,857,317
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Hemali Phatnani · New York University School Of Medicine$12,272,612
- Paul John Norman · University Of Colorado Denver$11,564,211
- Tomasz Nowakowski · University Of California, San Francisco$11,131,798
- Forrest Christie Collman · Allen Institute$10,342,277
Research focus
Cell PhysiologyCigarette SmokeLungSamplingCohortCellsIn VitroPulmonary EmphysemaPhenotypeBindingHomeostasisFreezingProductionBloodBlood SpecimenPeripheral BloodNovel TherapeuticsResponseAntigensChronic Obstructive Pulmonary DiseaseImmune ResponseGenesB-LymphocytesImmune
Grant awards (9)
Detrimental Effects of B-Cell-Th17 Axis in Antiviral Immunity in Smokers.$799,998
R01 · FY2025 · HL
Protective effects of metformin against cigarette smoke-induced lung pathologies via regulation of fatty acids metabolism$696,100
R01 · FY2025 · HL · contact PI
Protective effects of metformin against cigarette smoke-induced lung pathologies via regulation of fatty acids metabolism$796,760
R01 · FY2024 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$626,411
R01 · FY2024 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$680,755
R01 · FY2023 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$719,617
R01 · FY2022 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$643,981
R01 · FY2021 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$49,060
R01 · FY2021 · HL · contact PI
B cell-adaptive Immune Profile in Emphysema-predominant COPD$706,416
R01 · FY2020 · HL · contact PI